Detalhe da pesquisa
1.
Defining the Biology of Estrogen Receptor-Low-Positive Breast Cancer.
Ann Surg Oncol
; 31(4): 2244-2252, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38161200
2.
Immunotherapy for Early-Stage Triple Negative Breast Cancer: Is Earlier Better?
Curr Oncol Rep
; 26(1): 21-33, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38198112
3.
Adjuvant Olaparib for Germline BRCA Carriers With HER2-Negative Early Breast Cancer: Evidence and Controversies.
Oncologist
; 28(7): 565-574, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37210568
4.
Nodal Positivity in Early-Stage Triple-Negative Breast Cancer: Implications for Preoperative Immunotherapy.
Ann Surg Oncol
; 30(1): 100-106, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35941343
5.
Utility of the 21-Gene Recurrence Score in Node-Positive Breast Cancer.
Oncology (Williston Park)
; 35(2): 77-84, 2021 Feb 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33577165
6.
Phase 2 study of buparlisib (BKM120), a pan-class I PI3K inhibitor, in patients with metastatic triple-negative breast cancer.
Breast Cancer Res
; 22(1): 120, 2020 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33138866
7.
Evolution of HER2 expression between pre-treatment biopsy and residual disease after neoadjuvant therapy for breast cancer.
Eur J Cancer
; 201: 113920, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38368741
8.
Prognosis and treatment outcomes for patients with stage IA triple-negative breast cancer.
NPJ Breast Cancer
; 10(1): 26, 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38575691
9.
Clinicogenomic characterization of inflammatory breast cancer.
bioRxiv
; 2024 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38766070
10.
PD-1 blockade and CDK4/6 inhibition augment nonoverlapping features of T cell activation in cancer.
J Exp Med
; 220(4)2023 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36688919
11.
Combination Therapies to Improve the Efficacy of Immunotherapy in Triple-negative Breast Cancer.
Mol Cancer Ther
; 22(11): 1304-1318, 2023 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37676980
12.
Clinical outcomes of de novo metastatic HER2-positive inflammatory breast cancer.
NPJ Breast Cancer
; 9(1): 50, 2023 Jun 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37268625
13.
Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer.
Nat Commun
; 14(1): 7496, 2023 11 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37980405
14.
Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis.
Nat Cancer
; 4(1): 128-147, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36585450
15.
Understanding resistance to immune checkpoint inhibitors in advanced breast cancer.
Expert Rev Anticancer Ther
; 22(2): 141-153, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34919490
16.
Emerging Targeted Therapies for Early Breast Cancer.
Drugs
; 82(14): 1437-1451, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36207645
17.
Dermal Lymphatic Invasion, Survival, and Time to Recurrence or Progression in Inflammatory Breast Cancer.
Am J Clin Oncol
; 44(9): 449-455, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34149037
18.
Genomic Characterization of de novo Metastatic Breast Cancer.
Clin Cancer Res
; 27(4): 1105-1118, 2021 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33293374
19.
Clinical Pan-Cancer Assessment of Mismatch Repair Deficiency Using Tumor-Only, Targeted Next-Generation Sequencing.
JCO Precis Oncol
; 4: 1084-1097, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35050773
20.
Tumor Mutational Burden and PTEN Alterations as Molecular Correlates of Response to PD-1/L1 Blockade in Metastatic Triple-Negative Breast Cancer.
Clin Cancer Res
; 26(11): 2565-2572, 2020 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32019858